A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants
暂无分享,去创建一个
R. Handgretinger | A. Gavrilov | D. Hartl | J. Kuemmerle-Deschner | N. Rieber | I. Schäfer | J. Kümmerle-Deschner | H. Öz | Anurag Singh | T. Endres | L. Hofer | A. Singh